These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15317746)

  • 1. Reversal of linezolid-associated cytopenias, but not peripheral neuropathy, by administration of vitamin B6.
    Spellberg B; Yoo T; Bayer AS
    J Antimicrob Chemother; 2004 Oct; 54(4):832-5. PubMed ID: 15317746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer.
    Youssef S; Hachem R; Chemaly RF; Adachi J; Ying J; Rolston K; Raad I
    J Antimicrob Chemother; 2008 Feb; 61(2):421-4. PubMed ID: 18174198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN; Hong SB; Oh YM; Kim MN; Lim CM; Lee SD; Koh Y; Kim WS; Kim DS; Kim WD; Shim TS
    J Antimicrob Chemother; 2006 Sep; 58(3):701-4. PubMed ID: 16857689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
    J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral neuropathy in an adolescent treated with linezolid.
    Linam WM; Wesselkamper K; Gerber MA
    Pediatr Infect Dis J; 2009 Feb; 28(2):149-51. PubMed ID: 19116599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey.
    Beekmann SE; Gilbert DN; Polgreen PM;
    Diagn Microbiol Infect Dis; 2008 Dec; 62(4):407-10. PubMed ID: 18929458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linezolid for the treatment of adults with bone and joint infections.
    Falagas ME; Siempos II; Papagelopoulos PJ; Vardakas KZ
    Int J Antimicrob Agents; 2007 Mar; 29(3):233-9. PubMed ID: 17204407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid-induced optic neuropathy.
    Saijo T; Hayashi K; Yamada H; Wakakura M
    Am J Ophthalmol; 2005 Jun; 139(6):1114-6. PubMed ID: 15953450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibly linezolid-induced peripheral and central neurotoxicity: report of four cases.
    Ferry T; Ponceau B; Simon M; Issartel B; Petiot P; Boibieux A; Biron F; Chidiac C; Peyramond D
    Infection; 2005 Jun; 33(3):151-4. PubMed ID: 15940417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Koh WJ; Kwon OJ; Gwak H; Chung JW; Cho SN; Kim WS; Shim TS
    J Antimicrob Chemother; 2009 Aug; 64(2):388-91. PubMed ID: 19468028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
    Jauregui LE; Babazadeh S; Seltzer E; Goldberg L; Krievins D; Frederick M; Krause D; Satilovs I; Endzinas Z; Breaux J; O'Riordan W
    Clin Infect Dis; 2005 Nov; 41(10):1407-15. PubMed ID: 16231250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactic acidosis and linezolid-induced pancytopaenia.
    Carbajo T; Fenollosa M; Pons R; Calvo C
    Nefrologia; 2011; 31(1):107-8. PubMed ID: 21270922
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid for the treatment of multidrug-resistant tuberculosis.
    Fortún J; Martín-Dávila P; Navas E; Pérez-Elías MJ; Cobo J; Tato M; De la Pedrosa EG; Gómez-Mampaso E; Moreno S
    J Antimicrob Chemother; 2005 Jul; 56(1):180-5. PubMed ID: 15911549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.
    Wilcox MH; Tack KJ; Bouza E; Herr DL; Ruf BR; Ijzerman MM; Croos-Dabrera RV; Kunkel MJ; Knirsch C
    Clin Infect Dis; 2009 Jan; 48(2):203-12. PubMed ID: 19072714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of optic neuropathy after short-term linezolid use in a patient with acute lymphocytic leukemia.
    Joshi L; Taylor SR; Large O; Yacoub S; Lightman S
    Clin Infect Dis; 2009 Apr; 48(7):e73-4. PubMed ID: 19231981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Our experience with linesolid usage in newborn children].
    Atanasova V; Slavkova N; Rosmanova R
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():60-2. PubMed ID: 18173016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.